Bank of New York Mellon Corp Cuts Shares in Waldencast plc (NASDAQ:WALD)

Bank of New York Mellon Corp lessened its holdings in shares of Waldencast plc (NASDAQ:WALD – Free Report) by 7.2% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 67,787 shares of the company’s stock after selling 5,262 shares during the quarter. Bank of New York Mellon Corp owned about 0.06% of Waldencast worth $243,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have recently added to or reduced their stakes in the company. Catalina Capital Group LLC purchased a new stake in Waldencast in the first quarter valued at about $73,000. Norden Group LLC purchased a new stake in Waldencast in the 1st quarter valued at about $92,000. Bleakley Financial Group LLC acquired a new position in Waldencast in the 1st quarter worth about $142,000. Finally, Zeno Equity Partners LLP purchased a new position in Waldencast in the fourth quarter valued at approximately $224,278,000. Institutional investors and hedge funds own 41.97% of the company’s shares.

Waldencast stock performance

Shares of WALD stock opened at $3.78 on Friday. Waldencast plc has a 1 year low of $2.40 and a 1 year high of $12.00. The firm has a fifty day moving average price of $3.32 and a two hundred day moving average price of $4.39. The company has a current ratio of 1.47, a quick ratio of 0.78, and a debt-to-equity ratio of 0.21.

Analysts on Wall Street are forecasting an increase

A number of analysts recently issued reports on the company. DA Davidson upped their target price on Waldencast from $6.50 to $7.25 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Telsey Advisory Group cut their price target on Waldencast from $8.00 to $6.00 and set an “outperform” rating for the company in a report on Thursday, August 29th.

Read the latest stock report on Waldencast

Waldencast profile

(Free Report)

Waldencast plc operates in the beauty and wellness business. The company is engaged in the development, acquisition, acceleration and expansion of various brands. Offers cosmetic, over-the-counter and prescription products under the Obagi Medical, Obagi Clinical and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by doctors’ offices, spas and estheticians.

Featured stories

Want to see what other hedge funds own WALD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waldencast plc (NASDAQ:WALD – Free Report).

Get news and reviews for Waldencast Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Waldencast and related companies with MarketBeat.com ‘s FREE daily email newsletter.